LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 143 filers reported holding LEMAITRE VASCULAR INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $586,000 | +23.4% | 18,000 | 0.0% | 0.11% | +37.5% |
| Q2 2020 | $475,000 | +5.8% | 18,000 | 0.0% | 0.08% | -7.0% |
| Q1 2020 | $449,000 | -62.1% | 18,000 | -45.5% | 0.09% | -42.7% |
| Q4 2019 | $1,186,000 | +5.1% | 33,000 | 0.0% | 0.15% | -11.2% |
| Q3 2019 | $1,128,000 | +6.1% | 33,000 | -13.2% | 0.17% | +11.2% |
| Q2 2019 | $1,063,000 | -9.8% | 38,000 | 0.0% | 0.15% | -8.4% |
| Q1 2019 | $1,178,000 | +31.2% | 38,000 | 0.0% | 0.17% | +12.2% |
| Q4 2018 | $898,000 | -39.0% | 38,000 | 0.0% | 0.15% | -12.4% |
| Q3 2018 | $1,472,000 | +15.7% | 38,000 | 0.0% | 0.17% | +21.6% |
| Q2 2018 | $1,272,000 | -7.6% | 38,000 | 0.0% | 0.14% | -14.7% |
| Q1 2018 | $1,377,000 | +13.8% | 38,000 | 0.0% | 0.16% | +2.5% |
| Q4 2017 | $1,210,000 | -14.9% | 38,000 | 0.0% | 0.16% | -29.0% |
| Q3 2017 | $1,422,000 | -5.1% | 38,000 | -20.8% | 0.22% | -13.2% |
| Q2 2017 | $1,499,000 | +4.9% | 48,000 | -17.2% | 0.26% | -13.4% |
| Q1 2017 | $1,429,000 | – | 58,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |